Search
Sumario de resultados
TIpos de contenido
Fecha
-
OfferSr. Project Manager
-
NewZETA & INOSIM: Partnering for Industry 4.0 Success in Spain
ZETA, a leading provider of end-to-end solutions for the biopharma and pharma industry, has announced the acquisition of a majority stake in INOSIM Software GmbH, a German company that specializes in
-
NewBiorizon Biotech and its Trietech© technology, world leader in microalgae-based agricultu...
Biorizon Biotech has become a global leader in agricultural biotechnology and is renowned for its innovative microalgae-based Trietech© technology. Since it was founded, the company has transformed
-
NewNatac starts up the largest omega-3 production plant in Spain
The factory, which has a production capacity of up to 10,000 tonnes per year, is equipped with state-of-the-art technology for processing omega-3 oil. The first oil production tests began in July and
-
NewThe Comparative Medicine and Bioimage Centre of Catalonia celebrates its fifth anniversary
Prominent researchers and health professionals shared success stories developed at the centre and discussed the future of fields such as personalised medicine, bioimaging, and robotic surgery.
-
NewRevolutionary CAR-T Cell Therapies: A New Era in Cancer Treatment
Promega's contribution to the development and verification of genetically modified CAR-T cells is driving innovation in cancer immunotherapy.
-
NewAMSbiopharma launches an innovation plan to strengthen its position in the biopharmaceutic...
AMSbiopharma’s Innovation Plan goes beyond improving internal processes, adopting a comprehensive approach that encompasses innovation in services, technology, and organization.
-
NewWe analyze the challenges and opportunities for promoting and developing biotechnological ...
Proposals such as improving the financing environment for disruptive innovation, startups, and expanding companies, or maximizing the impact of the European Health Data Space, among others, are
-
CompanySIMBIONTE
-
NewBiotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com...
It is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority (approximately 85%) being non-Hodgkin.
-
Press releaseBiotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com...
There are more than 40 types of lymphomas that can generally be grouped into two major subgroups: Hodgkin lymphoma and non-Hodgkin lymphoma. It is estimated that in 2024, around 12,400 new cases of
-
NewBiotechnology, at the forefront of the fight against sepsis, one of the world's most serio...
The use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in monocytes ex vivo are examples of the latest advancements against sepsis.
-
Press releaseBiotechnology, at the forefront of the fight against sepsis, one of the world's most serio...
Sepsis is a potentially life-threatening condition that occurs when the body's immune system reacts in an extreme way to an infection, causing organ dysfunction. 22% of sepsis survivors who have
-
New#NewAseBioMember | “AseBio, for our small biotech, is a platform that offers a multitude o...
Meet Telomere Therapeutics, our new member. We spoke with Ana Margarita Maldonado, CMC & Regulatory Manager.
-
NewORYZON receives “Intention to grant” communication for patent relating to the use of vafid...
The intention to grant is a formal communication from the EPO in which it indicates that the patent application has reached the status where it is allowed for issuance as a patent.
-
NewBiological Sex Differences in Health: Challenges and Opportunities for Personalised Medici...
Biological sex should be considered as a variable in all health-related biomedical research.
-
NewIBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy efectiveness by 40% in pa...
Ibrilatazar is an oral drug with a novel mechanism of acton that induces autophagy through the inducton of ER-stress and the inhibiton of the PI3K/Akt/mTOR pathway, which is crucial for cellular
-
NewORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadade...
Exploring the triple combination with venetoclax and azacitidine. Study sponsored by Oregon Health & Science University (OHSU).
-
NewBiotechnology Applied to Agriculture: Key to Addressing Challenges Such as Hunger, Climate...
The optimization of soil nutrient utilization, crops better adapted to climate change, or maximizing pest control through the digitalization of pesticide application are among the main areas of
-
Press releaseBiotechnology Applied to Agriculture: Key to Addressing Challenges Such as Hunger, Climate...
The optimization of soil nutrient utilization, crops better adapted to climate change, or maximizing pest control through the digitalization of pesticide application are among the main areas of
-
NewBIOSPAIN 2023, finalist in the XIX edition of the Eventoplus Awards for "Best Congress"
The Eventoplus Awards are the most prestigious recognition in the events and meetings sector in Spain and Portugal, with the winners to be announced on September 17.